Compare CCS & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCS | SDGR |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 2020 |
| Metric | CCS | SDGR |
|---|---|---|
| Price | $54.27 | $22.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $78.00 | $25.57 |
| AVG Volume (30 Days) | 193.9K | ★ 3.0M |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ 2.09 | N/A |
| Revenue | ★ $4,117,816,000.00 | $255,869,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.43 | $3.09 |
| P/E Ratio | $26.60 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $47.28 | $10.95 |
| 52 Week High | $76.00 | $33.78 |
| Indicator | CCS | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 32.97 | 38.46 |
| Support Level | $51.57 | $11.27 |
| Resistance Level | $55.40 | $31.59 |
| Average True Range (ATR) | 1.93 | 2.07 |
| MACD | -0.25 | -1.06 |
| Stochastic Oscillator | 9.54 | 0.71 |
Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.